VistaGen Therapeutics, Inc. (VTGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.58
Day's range
$0.62

Vistagen Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
COMMODORE CAPITAL LP 08/14/2026 2.79 M $630.23 K   100.00% 6.49%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.57 M $355.77 K   0.00% 3.66%
TWO SIGMA INVESTMENTS, LP 08/14/2026 847.99 K $191.65 K   80.57% 1.97%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 794.58 K $178.00 K   34.75% 1.85%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 730.50 K $165.09 K   150.77% 1.70%
STEMPOINT CAPITAL LP 08/14/2026 616.75 K $17.28 K   0.00% 1.44%
IKARIAN CAPITAL, LLC 08/14/2026 519.08 K $117.31 K   0.00% 1.21%
ADVISORSHARES INVESTMENTS LLC 08/11/2026 438.64 K $99.13 K   58.29% 1.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 415.40 K $95.54 K   928.22% 0.97%
LUMINUS MANAGEMENT LLC 08/14/2026 403.12 K $91.10 K   1.78% 0.94%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 365.00 K $82.51 K   -19.50% 0.85%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 351.14 K $79.36 K   -53.25% 0.82%
BLACKROCK, INC. 08/07/2026 345.43 K $78.07 K   -22.98% 0.80%
MILLENNIUM MANAGEMENT LLC 08/14/2026 306.60 K $69.29 K   43.27% 0.71%
GROUP ONE TRADING, L.P. 08/14/2026 304.39 K $68.79 K   1,431.50% 0.71%
VERDAD ADVISERS, LP 08/14/2026 293.34 K $66.30 K   58.62% 0.68%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 217.70 K $49.20 K   0.00% 0.51%
TUDOR INVESTMENT CORP ET AL 08/14/2026 167.00 K $37.74 K   100.00% 0.39%
JANE STREET GROUP, LLC 08/14/2026 164.83 K $37.25 K   -39.58% 0.38%
CITADEL ADVISORS LLC 09/02/2026 149.00 K $33.67 K   -37.71% 0.35%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 134.57 K $30.41 K   0.00% 0.31%
STATE STREET CORP 08/07/2026 121.11 K $27.37 K   0.00% 0.28%
XTX TOPCO LTD 08/14/2026 118.38 K $26.75 K   -22.55% 0.28%
NORTHERN TRUST CORP 08/13/2026 80.82 K $18.27 K   11.24% 0.19%
JANE STREET GROUP, LLC 08/14/2026 76.50 K $17.29 K   229.74% 0.18%
CITADEL ADVISORS LLC 09/02/2026 68.84 K $15.56 K   100.00% 0.16%
VIRTU FINANCIAL LLC 08/13/2026 66.02 K $15.00 K   100.00% 0.15%
UBS GROUP AG 08/13/2026 57.83 K $13.07 K   -26.55% 0.13%
DIADEMA PARTNERS LP 08/14/2026 57.70 K $13.04 K   100.00% 0.13%
GSA CAPITAL PARTNERS LLP 08/06/2026 54.58 K $12.00 K   9.51% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 44.30 K $10.19 K   100.00% 0.10%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 43.89 K $10.08 K   961.89% 0.10%
CONFLUENCE WEALTH SERVICES, INC. 07/22/2026 32.61 K $7.37 K   100.00% 0.08%
SCIENTECH RESEARCH LLC 08/14/2026 30.28 K $6.84 K   100.00% 0.07%
R SQUARED LTD 08/05/2026 27.75 K $6.27 K   100.00% 0.06%
KESTRA ADVISORY SERVICES, LLC 07/28/2026 26.00 K $5.88 K   0.00% 0.06%
JANE STREET GROUP, LLC 08/14/2026 24.50 K $5.54 K   100.00% 0.06%
HIGHTOWER ADVISORS, LLC 08/05/2026 20.63 K $4.66 K   0.00% 0.05%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 18.14 K $4.10 K   1,053.69% 0.04%
BANK OF AMERICA CORP /DE/ 08/14/2026 16.57 K $3.75 K   100.00% 0.04%
TRUVESTMENTS CAPITAL LLC 08/12/2026 15.54 K $3.51 K   -8.55% 0.04%
CITADEL ADVISORS LLC 09/02/2026 15.10 K $3.41 K   -57.70% 0.04%
FARTHER FINANCE ADVISORS, LLC 07/17/2026 15.00 K $3.39 K   100.00% 0.03%
RAYMOND JAMES FINANCIAL INC 08/14/2026 14.85 K $3.36 K   -0.22% 0.03%
SIMPLEX TRADING, LLC 08/12/2026 14.30 K $3.23 K   -84.05% 0.03%
DEUTSCHE BANK AG\ 08/07/2026 12.00 K $2.76 K   100.00% 0.03%
STONEX GROUP INC. 08/12/2026 10.84 K $6.62 K   -28.67% 0.03%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 10.81 K $2.44 K   0.00% 0.03%
PERFORMA LTD (US), LLC 08/03/2026 5.50 K $1.24 K   -26.67% 0.01%
CITIGROUP INC 08/03/2026 3.82 K $864   382,100.00% 0.01%

Vistagen Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 78 institutional investors and hedge funds held shares of Vistagen Therapeutics Inc.. The most heavily invested institutionals were:

COMMODORE CAPITAL LP: 2.79 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.57 M

TWO SIGMA INVESTMENTS, LP: 847,992

ACADIAN ASSET MANAGEMENT LLC: 794,579

RENAISSANCE TECHNOLOGIES LLC: 730,500

StemPoint Capital LP: 616,749

27.40% of Vistagen Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 14.60 M shares in the last 24 months. This purchase volume represents approximately $9.05 M in transactions.